Raylene’s Goal

Raylene Hollrah was diagnosed with BIA-ALCL and was distraught over the fact that not even a memorandum or information document was made available to her. One of her goals in life is to make this kind of information mandatory for women seeking to have breast augmentation and a notification to women with breast implants for reconstruction after a mastectomy.

Original 2011 FDA announcement:

Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses (January 2011)

Most recent FDA announcement:

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) (August 2018)